Events | 2019.07.01
Squarex Appoints Biopharmaceutical Industry Veteran Jack V. Talley as Chief Executive Officer
ST. PAUL, Minn., July 1, 2019 /PRNewswire/ -- Squarex, a clinical-stage pharmaceutical company developing a topical immunomodulator for the long-term prevention of recurrent cold sores and other diseases, today announced the appointment of Jack V. Talley, Jr. as Chief Executive Officer....
For more information, please visit
https://www.prnewswire.com:443/news-rele[...]ecutive-officer-300878454.html
